-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on ArcBest, Lowers Price Target to $97

Benzinga·04/10/2025 17:53:25
Listen to the news
Goldman Sachs analyst Jordan Alliger maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $108 to $97.